Development of in vivo μCT evaluation of neovascularisation in tissue engineered bone constructs

被引:56
|
作者
Bolland, B. J. R. F. [1 ]
Kanczler, J. M. [1 ]
Dunlop, D. G. [1 ]
Oreffo, R. O. C. [1 ]
机构
[1] Univ Southampton, Inst Dev Sci, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England
基金
英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
neovascularisation; allograft; mu CT; tissue engineering; impaction bone grafting; adult human bone marrow stromal cells;
D O I
10.1016/j.bone.2008.02.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to an increasing aging population the need for innovative approaches to aid skeletal repair and reconstruction is a significant socio-economic increasing problem. The emerging discipline of tissue engineering has sort to augment the growth and repair of bone loss particularly in areas of trauma, degeneration and revision surgery. However, the initiation and development of a fully functional vascular network are critical for bioengineered bone to repair large osseous defects, whether the material is osteosynthetic (poly (D,L)-lactic acid, PLA) or natural bone allograft. Quantification and three-dimensional visualization of new vessel networks remain a problem in bone tissue engineering constructs. A novel technique utilising a radio-opaque dye and micro-computed tomography (mu CT) has been developed and applied to study angiogenesis in an impaction bone graft model. Tissue-engineered constructs combining human bone marrow stromal cells (HBMSC) with natural allograft and synthetic grafts (PLA) were impacted and implanted into the subcutis of MF-1 nu/nu mice for a period of 28 days. Microfil consisting of radio-opaque polymer was perfused through the mice and scanned using a Bench Top CT system for microcomputed tomography. Analysis of three-dimensional mu CT reconstructions demonstrated an increase in vessel volume and vessel number in the impacted scaffolds/HBMC compared to scaffolds alone. Vessel volume: allograft/HBMSC = 0.57 mm(3) +/- 0.19; allograft = 0.04 mm(3) +/- 0.04; PLA/HBMSC = 1.19 mm(3) +/- 0.31: and PLA = 0.12 mm(3) +/- 0.01. Penetrating vessel number: allograft/HBMSC = 22.33 3.21; allograft = 3.67 +/- 1.153; PLA/HBMSC = 32.67 +/- 8.33; and PLA = 7.67 +/- 3.06. Type 1 collagen and von Willebrand factor immunohistochemistry in scaffold/HBMSC constructs indicated the osteogenic cell phenotype, and new blood vessel formation respectively. Contrast-enhanced 3D reconstructions facilitated the visualization and quantification of neovascularisation. This novel technique has been used to demonstrate neovascularisation in impacted tissue engineered constructs providing a facile approach with wide experimental application. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 50 条
  • [1] In Vivo Tracking of Tissue Engineered Constructs
    Gil, Carmen J.
    Tomov, Martin L.
    Theus, Andrea S.
    Cetnar, Alexander
    Mahmoudi, Morteza
    Serpooshan, Vahid
    MICROMACHINES, 2019, 10 (07)
  • [2] Effects of μCT radiation on tissue engineered bone-like constructs
    Kraehenbuehl, Thomas P.
    Stauber, Martin
    Ehrbar, Martin
    Weber, Franz
    Hall, Heike
    Mueller, Ralph
    BIOMEDIZINISCHE TECHNIK, 2010, 55 (04): : 245 - 250
  • [3] Cryopreservation of tissue engineered constructs for bone
    Kofron, MD
    Opsitnick, NC
    Attawia, MA
    Laurencin, CT
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2003, 21 (06) : 1005 - 1010
  • [4] An Overview of Methods for the In Vivo Evaluation of Tissue-Engineered Skin Constructs
    Lammers, Gerwen
    Verhaegen, Pauline D. H. M.
    Ulrich, Magda M. W.
    Schalkwijk, Joost
    Middelkoop, Esther
    Weiland, Daniela
    Nillesen, Suzan T. M.
    Van Kuppevelt, Toin H.
    Daamen, Willeke F.
    TISSUE ENGINEERING PART B-REVIEWS, 2011, 17 (01) : 33 - 55
  • [5] Evaluation of Preclinical Models for the Testing of Bone Tissue-Engineered Constructs
    Zeiter, Stephan
    Koschitzki, Kim
    Alini, Mauro
    Jakob, Franz
    Rudert, Maximilian
    Herrmann, Marietta
    TISSUE ENGINEERING PART C-METHODS, 2020, 26 (02) : 107 - 117
  • [6] Prefabrication of tissue engineered constructs - a viable strategy for neovascularisation - a model tested on rabbits
    Feucht, A.
    The, H. Nguyen
    Storck, K.
    Staudenmaier, R.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 299 - 299
  • [7] Visualizing the Development of Tissue Engineered Bone Constructs with a Low Field Benchtop MRI
    Xu, Huihui
    PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON BIOLOGICAL ENGINEERING AND PHARMACY (BEP 2016), 2016, 3 : 400 - 402
  • [8] Fabrication and in vivo perfusion of vascularized tissue engineered constructs
    Campbell, Rachel
    Hernandez, Karina A.
    Boyko, Tatiana
    Delnero, Peter
    Garcia, Daniel
    Reiffel, Alyssa J.
    Spector, Jason A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S156 - S157
  • [9] Bioreactor for development of tissue engineered cartilage constructs
    Saini, Sunil
    Wick, Timothy M.
    American Society of Mechanical Engineers, Bioengineering Division (Publication) BED, 1999, 42 : 131 - 132
  • [10] Tissue engineered hybrid tooth-bone constructs
    Zhang, Weibo
    Abukawa, Harutsugi
    Troulis, Maria J.
    Kaban, Leonard B.
    Vacanti, Joseph P.
    Yelick, Pamela C.
    METHODS, 2009, 47 (02) : 122 - 128